Notably, we identified a strong relationship with circulating LBP, which in turn correlated with other markers of systemic inflammation, a loss of beneficial microbes such as butyrate-producing bacteria, and a higher BMI, indicating that diverse modifiable factors may influence LPS/inflammation-driven metabolic disease in this population. The gene discussed is LBP; the disease is metabolic disease.